Small Intestinal Bacterial Overgrowth, commonly called SIBO, occurs when bacteria that normally live in the large intestine migrate into the small intestine in abnormally high numbers. The small intestine typically contains far fewer bacteria than the large intestine. When this balance shifts, the excess bacteria can interfere with digestion and nutrient absorption, creating a range of uncomfortable symptoms.
Get Your Free Conchas Baking Guide →
The small intestine has several natural defenses that normally keep bacterial populations low. The ileocecal valve, located where the small intestine meets the large intestine, acts as a barrier. Stomach acid kills many bacteria before they reach the small intestine. The small intestine also moves food along through muscular contractions called peristalsis, which helps prevent bacterial overgrowth. When any of these protective mechanisms weaken or fail, SIBO can develop.
According to research published in medical journals, SIBO affects an estimated 5 to 15 percent of people without digestive disorders, though rates are higher in certain populations. Among people with irritable bowel syndrome (IBS), studies suggest SIBO may be present in 30 to 60 percent of cases, depending on which test is used and which population is studied. The condition appears more frequently in older adults and people with certain underlying health conditions.
Several factors can increase the risk of developing SIBO. These include a history of abdominal surgery that may have damaged the intestinal valve, autoimmune conditions affecting the digestive tract, diabetes, certain medications like proton pump inhibitors that reduce stomach acid, and conditions that slow intestinal movement such as hypothyroidism. Food poisoning, specifically from bacteria like Campylobacter, has been linked to SIBO development in some people. Additionally, structural problems in the small intestine or adhesions from previous surgery can create pockets where bacteria accumulate.
Practical Takeaway: Understanding that SIBO results from specific physical or chemical changes in the digestive system—not from contamination or poor hygiene—helps frame the condition accurately. Several protective mechanisms normally prevent bacterial overgrowth, and when these mechanisms fail, SIBO becomes possible. Knowing your own risk factors, especially prior surgery or chronic health conditions, provides context for discussing SIBO with a healthcare provider.
SIBO symptoms often overlap with IBS, making diagnosis challenging. Common symptoms include bloating and abdominal distention, excessive gas and belching, abdominal pain or discomfort, diarrhea, constipation, or alternating patterns of both. Some people experience food sensitivities, particularly to carbohydrates and fermented foods. Fatigue, nutrient deficiencies, and unintended weight loss can occur due to malabsorption. These symptoms typically worsen after eating and may improve temporarily with bowel movements or gas passage.
Learn About Luxury Apartment Costs in Calumet City →
The hydrogen and methane breath test represents the most commonly used diagnostic method for SIBO. This test measures gases that bacteria produce when they ferment carbohydrates. A person fasts overnight, then drinks a solution containing either glucose or lactulose. Over two to three hours, breath samples are collected at intervals and analyzed for hydrogen and methane levels. Elevated levels at specific time points suggest bacterial overgrowth in the small intestine. This test is non-invasive and widely available through gastroenterology offices and some direct-to-consumer laboratories.
Small intestinal aspiration and culture, considered the gold standard test, involves passing an endoscope into the small intestine and collecting fluid samples directly. Bacterial counts above 10,000 colony-forming units per milliliter of fluid indicate SIBO. However, this test is invasive, more expensive, and less commonly performed than breath testing. It may be used when breath test results are unclear or when other diagnoses are being investigated.
Breath test interpretation requires understanding that different labs use different cut-off values for abnormal results. Some labs define SIBO based on peak hydrogen levels, while others look at the rise in hydrogen above baseline, or the early rise pattern suggesting bacteria in the small intestine rather than the colon. The type of sugar used—glucose or lactulose—also affects results. Glucose is absorbed more readily by the intestinal lining, so abnormal results with glucose testing may indicate more severe overgrowth. Lactulose is less absorbed, potentially revealing milder cases. A healthcare provider can interpret which test is most appropriate for an individual's symptoms.
Practical Takeaway: Symptom patterns that worsen after meals, especially after carbohydrate-rich foods, warrant a conversation with a healthcare provider about SIBO testing. The breath test is the most accessible diagnostic option, though results require professional interpretation. Understanding your symptoms in relation to food intake and timing helps provide useful information during diagnosis.
Dietary modification represents a foundational part of SIBO management because it directly addresses what bacteria in the small intestine ferment. When people eat foods that bacteria can easily ferment—primarily certain carbohydrates—bacterial metabolism produces the gas and symptoms associated with SIBO. By reducing these fermentable foods, people often experience symptom relief, though dietary changes alone do not eliminate the bacterial overgrowth itself.
Get Your Free Python Beginner Information Guide →
The Low FODMAP diet is the most researched dietary approach for SIBO. FODMAP stands for Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols. This diet restricts foods high in these short-chain carbohydrates that bacteria ferment quickly. High FODMAP foods include wheat and rye, certain fruits like apples and pears, onions and garlic, legumes, and sugar alcohols like sorbitol. Research published in gastroenterology journals indicates that 60 to 80 percent of people with SIBO report symptom improvement on a Low FODMAP diet, even before antimicrobial treatment. However, the Low FODMAP diet is a symptom management tool, not a cure for SIBO, and symptoms typically return when regular foods are reintroduced if the underlying bacterial overgrowth remains untreated.
The Specific Carbohydrate Diet (SCD) restricts disaccharides and polysaccharides, allowing only monosaccharides that are more easily absorbed. The SCD is stricter than Low FODMAP and can be more challenging to follow long-term. Some people find it helpful for severe symptoms. The Elemental Diet, which consists of nutrients in pre-digested form requiring minimal bacterial fermentation, is sometimes used short-term during the initial phase of treatment. This diet is nutritionally complete but unpalatable for many, typically used for two to four weeks rather than indefinitely.
Practical dietary strategies include eating smaller, more frequent meals rather than large meals; chewing food thoroughly; spacing meals and beverages appropriately; limiting fiber intake during acute symptom periods (though some fiber is necessary for digestive health); and identifying individual trigger foods through careful observation. Keeping a food and symptom diary for one to two weeks reveals patterns. For example, one person might react strongly to stone fruits while tolerating other foods, while another has no issues with fruits but cannot tolerate garlic.
Practical Takeaway: Dietary changes can provide significant symptom relief but should be combined with other treatments to address the root cause. A Low FODMAP diet offers the most research support for SIBO symptom management. Tracking personal food reactions helps identify individual tolerances rather than following rigid rules. Consulting a registered dietitian familiar with SIBO ensures nutritional adequacy while managing symptoms.
Antimicrobial treatment aims to reduce bacterial overgrowth in the small intestine. Rifaxomicin, a non-absorbed antibiotic, is the most commonly prescribed medication for SIBO. Non-absorbed means the medication stays in the gastrointestinal tract rather than entering the bloodstream, minimizing systemic side effects. Rifaxomicin targets a broad spectrum of gram-negative and gram-positive bacteria and has demonstrated effectiveness in clinical trials. A typical course lasts 14 days. Studies show that approximately 40 to 45 percent of people achieve normal breath test results after rifaxomicin treatment, with symptom improvement rates higher than test normalization rates.
Free Guide to Hemorrhoid Treatment Options →
Neomycin, an older antibiotic, is also non-absorbed and used for SIBO treatment. It is less expensive
This guide is for general information only and is not medical, financial, legal, or other professional advice. For decisions specific to your situation, consult a qualified professional. See our Editorial Policy.